DES PLAINES, Ill., Sept. 18 /PRNewswire-USNewswire/ -- The Emergency Nurses Association (ENA) today announced the corporate sponsors for the 2008 ENA Annual Conference to be held in Minneapolis, MN, on September 25 - 27, 2008. This year's sponsors are sanofi-aventis U.S. and Bristol-Myers Squibb / Sanofi Pharmaceuticals Partnership, Catholic Healthcare West, LifeSync Corporation, The Medicines Company, Otsuka America Pharmaceuticals Inc, and Physio-Control. "We are so pleased that these companies have chosen to support emergency nurses from across the country through their sponsorship of the 2008 ENA Annual Conference," said Denise King, RN, MSN, CEN, 2008 president, ENA. "Each of these companies has shown their commitment to improved patient care through their support of this meeting. By sponsoring the Annual Conference, each of these companies is directly contributing to the continued improvement of emergency care." The 2008 ENA Annual Conference will explore the conference theme, Pathways to Discovery, with in-depth reviews of national issues facing emergency care professionals, professional development sessions on career and management issues and an exhibit hall featuring a plethora of suppliers of products and services for the emergency care environment. About the 2008 Annual Conference Sponsors Catholic Healthcare West is a not-for-profit healthcare system with over 40 facilities in California, Nevada and Arizona. They can be found in the heart of the communities they serve, offering care that combines state-of-the-art technologies with timeless values that reflect a commitment to healing. LifeSync Corporation is a medical device company committed to the development of innovative products that improve clinical outcomes for patients through the use of LifeSync(R) Wireless ECG products and technologies. The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, a procedure to clear restricted blood flow in arteries around the heart. The Company also has two products in late-stage development, CleviprexTM (clevidipine butyrate) injectable emulsion and cangrelor. Otsuka America Pharmaceuticals Inc. is a successful, innovative, fast-growing healthcare company that commercializes Otsuka-discovered and other product opportunities in North America, with a strong focus on and commitment to neuroscience, cardiology, oncology, and gastroenterology. The Company is part of the Otsuka Pharmaceutical Group, which is comprised of 104 companies and approximately 31,000 people around the world. Physio-Control pioneered defibrillation technology more than 50 years ago and provides LIFEPAK(R) products for cardiac emergencies in hospital emergency departments. For more information about the 2008 ENA Annual Conference, visit the ENA website at www.ena.org. About the Emergency Nurses Association The Emergency Nurses Association (ENA) is the only professional nursing association dedicated to defining the future of emergency nursing and emergency care through advocacy, expertise, innovation, and leadership. Founded in 1970, ENA serves as the voice of more than 35,000 members and their patients through research, publications, professional development, injury prevention, and patient education. Additional information is available at ENA's Web site, at www.ena.org.
SOURCE Emergency Nurses Association